DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Loibl S, Untch M, Burchardi N, Huober JB, Blohmer JU, Grischke EM. et al.
Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC).
J Clin Oncol 2018;
15 Suppl 36: 14
We do not assume any responsibility for the contents of the web pages of other providers.